This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Campylobacter | |
|---|---|
| Name | Campylobacter |
| Domain | Bacteria |
| Phylum | Proteobacteria |
| Classis | Epsilonproteobacteria |
| Ordo | Campylobacterales |
| Familia | Campylobacteraceae |
| Genus | Campylobacter |
Campylobacter is a genus of Gram-negative, microaerophilic bacteria notable for causing foodborne gastroenteritis and systemic infections in humans and animals. First identified in the early 20th century, these organisms have been studied across microbiology, infectious disease, veterinary medicine, and public health. Major species associated with human disease include C. jejuni and C. coli; outbreaks and sporadic cases link the genus to poultry, livestock, water, and environmental reservoirs.
Campylobacter belongs to a taxonomic framework shaped by historical and molecular studies involving scientists and institutions such as Antonie van Leeuwenhoek, Robert Koch, Louis Pasteur, Max von Pettenkofer, Robert Whittaker and laboratories at Centers for Disease Control and Prevention, World Health Organization, and university departments like Johns Hopkins University and University of Oxford. Morphologically, species are slender, curved rods or spirals exhibiting polar or bipolar flagella; classic descriptions appear alongside work from Alexander Fleming and methods developed at Pasteur Institute. Comparative taxonomy has been refined using techniques from groups including International Committee on Systematics of Prokaryotes, American Society for Microbiology, and sequencing centers at Sanger Institute.
Campylobacter species are microaerophilic, thermotolerant (many grow at 42 °C), and require enriched media. Physiological studies reference methods propagated at Harvard Medical School, Massachusetts Institute of Technology, and University of Cambridge. Genomic analyses from projects at National Institutes of Health, European Molecular Biology Laboratory, and Broad Institute revealed small genomes with high rates of recombination and phase variation; investigations cite pipelines used by GenBank, EMBL, and DDBJ. Mobile genetic elements, plasmids, and restriction-modification systems contribute to rapid genetic diversification similarly documented in studies at Max Planck Society and Wellcome Trust.
Campylobacter pathogenesis involves mucosal invasion, toxin production, and immune-mediated complications, topics explored in clinical centers such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. Typical clinical manifestations include acute gastroenteritis with fever, abdominal pain, and bloody diarrhea; severe sequelae include reactive arthritis and Guillain–Barré syndrome discussed in literature from World Health Organization, European Centre for Disease Prevention and Control, and case series reported by Centers for Disease Control and Prevention. Host factors studied at institutions like Imperial College London and Karolinska Institutet influence disease severity.
Epidemiological patterns show highest incidence in regions monitored by World Health Organization, European Centre for Disease Prevention and Control, and national public health agencies such as Public Health England and Centers for Disease Control and Prevention. Transmission pathways involve contaminated poultry and meat, unpasteurized milk, surface water, and direct animal contact; major source attribution studies have been conducted by teams at USDA, Food and Agriculture Organization, and universities including University of California, Davis and University of Sydney. Outbreak investigations reference methodologies used in responses by Federal Emergency Management Agency and multinational consortia like Global Outbreak Alert and Response Network.
Laboratory identification employs culture on selective media, microscopy, biochemical tests, and molecular assays developed by research groups at Roche Diagnostics, Abbott Laboratories, and academic centers such as University of California, San Francisco. Diagnostic algorithms used in clinical laboratories at Mayo Clinic and Mount Sinai Hospital integrate real-time PCR, MALDI-TOF mass spectrometry, and whole-genome sequencing platforms from vendors like Illumina and Oxford Nanopore Technologies; quality standards reference criteria from Clinical and Laboratory Standards Institute and regulatory bodies including Food and Drug Administration.
Management of Campylobacter infections centers on rehydration and, when indicated, antimicrobial therapy; agents include macrolides and fluoroquinolones discussed in guidelines from National Institute for Health and Care Excellence, Infectious Diseases Society of America, and European Society of Clinical Microbiology and Infectious Diseases. Antimicrobial resistance trends—particularly fluoroquinolone resistance linked to agricultural use—have been documented by researchers at Centers for Disease Control and Prevention, World Health Organization, and surveillance networks like Global Antimicrobial Resistance Surveillance System and European Antimicrobial Resistance Surveillance Network.
Control strategies combine farm-level interventions, food-processing standards, and consumer education promoted by Food and Agriculture Organization, World Health Organization, USDA, and national agencies such as Food Standards Agency. Measures include biosecurity in poultry production studied by researchers at Auburn University and University of Georgia, pasteurization standards enforced by Food and Drug Administration, and hazard analysis frameworks like Hazard Analysis and Critical Control Points applied in industry practices overseen by corporations including Tyson Foods and JBS USA.
Campylobacteriosis imposes a substantial global burden assessed in reports from World Health Organization, European Centre for Disease Prevention and Control, Centers for Disease Control and Prevention, and economic analyses produced by organizations like World Bank and Organisation for Economic Co-operation and Development. Costs arise from healthcare utilization, productivity loss, and food industry recalls managed by agencies such as USDA and corporations like Kraft Foods. Surveillance, prevention, and research agendas have been funded by bodies including National Institutes of Health, Bill & Melinda Gates Foundation, and regional public health institutes such as Public Health Agency of Canada.